key: cord-0840323-sbg1aivi
authors: McCosker, Laura K.; El-Heneidy, Asmaa; Seale, Holly; Ware, Robert S.; Downes, Martin J.
title: Strategies to improve vaccination rates in people who are homeless: A systematic review
date: 2022-04-26
journal: Vaccine
DOI: 10.1016/j.vaccine.2022.04.022
sha: 819083122cc0ff4c4183a7f6e07ce39029a4a6fd
doc_id: 840323
cord_uid: sbg1aivi

People who are homeless experience higher rates of vaccine-preventable disease, including COVID-19, than the general population, and poorer associated health outcomes. However, delivering vaccinations to people who are homeless is complex, and there is a lack of evidence to inform practice in this area. The aim of this systematic review is to: (a) identify, (b) analyse the characteristics of, and (c) evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless. Literature was retrieved from eight electronic databases. Studies undertaken in high-income countries, published in English, in a peer-reviewed journal, and in full-text were considered. No limits were placed on study design or date. A total of 1,508 articles were retrieved and, after the removal of duplicates, 637 were screened. Twenty-three articles, reporting on nineteen separate vaccination strategies for hepatitis A/B, influenza, herpes zoster, invasive pneumococcal disease, and diphtheria in people who are homeless, were selected for inclusion. All the strategies were effective at improving vaccination rates in, people who are homeless. Most strategies involved vaccination clinics and most were delivered, at least in part, by nurses. Other characteristics of successful strategies included: delivering vaccinations at convenient locations; using accelerated vaccination schedules (if available); vaccinating at the first appointment, regardless of whether a person’s vaccination history or serological status were known (if clinically safe); operating for a longer duration; offering training to staff about working with people who are homeless; widely promoting clinics; considering education, reminders, incentives, and co-interventions; ensuring no out-of-pocket costs; and working collaboratively with stakeholders, including people who are homeless themselves. These findings will inform evidence-based vaccination strategies, including for COVID-19, in people who are homeless, and improve associated health outcomes in this at-risk, hard-to-reach group.

'Homelessness' occurs when a person lacks access to suitable housing.(1) People who are homeless may be unsheltered, or they may live in temporary, overcrowded, substandard, untenable, or unsafe housing. (1) In OECD countries, rates of homelessness range from 0.004% in Japan to 0.86% in New Zealand. (1) In one-third of OECD countries, rates of homelessness are increasing, and this increase is likely to be amplified by the COVID-19 pandemic.

In comparison to the general population, people who are homeless experience poorer health and health outcomes, including in relation to vaccine-preventable diseases. People who are homeless experience higher rates of vaccine-preventable diseases including hepatitis A/B, (2) (3) (4) influenza, (5) invasive pneumococcal disease, (6) (7) (8) tuberculosis, (9) (10) (11) (12) and COVID-19. (13) (14) (15) (16) (17) (18) (19) People who are homeless who are diagnosed with COVID-19 are > 20 times more likely to be hospitalised, >10 times more likely to need intensive care, and > 5 times more likely to die. (20) .

There is a strong case for prioritising people who are homeless for vaccination. (21) However, delivering vaccination to people who are homeless is challenging. People who are homeless often lack information on vaccination, (22) they may consider vaccination a low priority,(22,23) they may not have the means to travel to a vaccination clinic, and they may be reluctant to trust (and so be unwilling to actively present to) clinics. (24) In comparison to the general population, people who are homeless have lower rates of vaccination. (25) There are no existing reviews about strategies to improve vaccination rates in people who are homeless and, so, a lack of evidence to inform practice in this area. This is problematic considering the world's largest vaccination effort, for COVID-19, is underway. This systematic review will address this gap. The review aims to: (a) identify, (b) analyse the characteristics of, and (c) evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless.

The PICO framework was used to develop eligibility criteria for this review. The 'population' was any person, of any age, considered 'homeless' using the OECD definition.(1) The 'intervention' was any strategy implemented to improve vaccination rates in people who are homeless. The 'comparator', if relevant, was standard approaches to vaccination. The 'outcome' was the strategy's: (a) characteristics, and (b) outcomes. Only studies undertaken in high-income countries, published in English, in a peer-reviewed journal, and in full-text were considered. All study designs were considered. The searches were not date-limited.

The databases searched were CINAHL, ClinicalTrials.gov, Cochrane Library, Embase, MEDLINE, PsycINFO, Scopus, and Web of Science. Citation chaining was undertaken.

The searches used two groups of keywords: those related to (a) 'homelessness', and (b).

'vaccination' (including 'immunisation'). Index terms and subject headings were used if available on the databases. The search strategy is provided in Supplement 1.

Search results were exported into EndNote X9. Duplicate items were removed. Items were screened in two steps: (a) for all items: by reading the title/abstract, then (b) for the remaining items: by reading the full text. Each step was completed by one researcher (LM) and checked by a second researcher (AE); where needed, agreement was achieved through discussion.

Data was extracted into an electronic table. Extraction was completed by one researcher (LM) and checked by a second researcher (AE); where needed, agreement was achieved through discussion. The items extracted included data about: (a) the study, (b) the study participants, (c) the strategy's characteristics, and (d) the strategy's outcomes.

Literature selected for inclusion was evaluated for risk of bias and quality. Randomised controlled trials (RCTs) were evaluated using the revised Cochrane Risk-of-Bias Tool for Randomised Controlled Trials (RoB 2),(26) cohort studies were evaluated using the Risk of Bias in Non-Randomised Studies of Interventions (ROBINS-1) tool, (27) and cross-sectional studies were evaluated using the Appraisal Tool or Cross-Sectional Studies (AXIS) tool.(28).

Quantitative analysis (e.g. meta-analysis) of the results was planned. If quantitative analysis was not possible, the results were to be analysed narratively using a thematic approach. 

The selection process is shown in Fig. 1 , as a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram [29] . The searches were conducted in two rounds to July 10, 2021, and returned 1508 articles. Eight hundred and seventyone duplicates were removed, leaving 637 unique articles for screening. During the screening of titles and abstracts, 554 articles were removed, leaving 83 articles. Approximately 10% of the articles excluded at this step were checked by a second researcher, and there was 100% concordance. Sixty-eight of the remaining articles were available in full-text. During the screening of full-texts, 43 articles were excluded. Articles were excluded primarily because they were not full-text, peerreviewed articles (e.g. they were conference posters or abstracts), or because they did not separate outcomes for people who are homeless from other groups. The reference lists of the remaining articles were then manually searched. An extra 19 articles were screened by title/abstract, and nine were read in full-text. One was selected for inclusion. (30) .

The selected articles were then, again, checked by a second researcher. After robust discussion, the researchers agreed to exclude three articles which had initially been included: one which reported vaccine effectiveness as the primary outcome,(31) one which reported on a screening program where vaccination was not a key component, (32) and one where 'immunisations' were discussed without any detail.(33) A final total of 23 articles were included. (30, .

Details about the studies are shown in Table 1 . The studies were published between 1998,(36) and 2021.(55) The majority (N = 16) were undertaken in the US, and there were also studies from Australia, (40, 48) Canada, (36, 42) France, (30) the Netherlands,(51) and the UK. (54) . All were quantitative studies, either cross-sectional or longitudinal. There were seven RCTs. (43) (44) (45) (46) (47) 53, 56) Some studies included a qualitative component, (41) or a cost analysis. (53) The studies were highly heterogeneous, and this precluded quantitative analysis. Data was instead analysed narratively, in themes according to the study characteristics and outcomes. Table 1A ..

The sample sizes in the studies ranged from 54 (34) to 1800 people.(51) They included people who were homeless in sheltered and unsheltered settings. Most studies (N = 12) focused on adults, defined as people aged ! 18 years (and sometimes as ! 16 years or ! 21 years), though there were also studies which included only children/youth/adolescents, (36, 49, 50) only older adults,(39) or a mix of age-groups. (42) Some studies focused on specific homeless sub-populations, including people using drugs, (51, 54) people with a history of incarceration,(45) stimulant-using gay/bisexual men or transgender women, (53) and men on parole. (46, 47) .

Details about the intervention characteristics outlined in this section are shown in Table 2:Table 2A. .

Intervention: Most studies (N = 20) involved vaccination clinics, either as stand-alone interventions or part of a broader public health initiative. Three studies involved strategies to identify people experiencing homelessness as they presented to hospital emergency departments, to flag them for vaccination. (35, 37, 38) There were three instances where data from a single strategy was reported in > 1 article, so nineteen unique strategies are examined.

Infectious diseases: Most studies (N = 16) involved hepatitis A and/or B vaccination, and the others involved vaccination for seasonal and/or pandemic influenza, (30, 34, 40, 41, 55) herpes zoster, (39) invasive pneumococcal disease,(52) and diphtheria. (50) Most (N = 19) involved vaccination for routine disease prevention; others involved disease outbreaks. (35, 37, 38, 51) .

Location: The studies reported on vaccination strategies delivered at locations frequented by, or easily accessible to, people who are homeless. Locations reported included shelters, (30, 34, 36, (43) (44) (45) 49, 55) day shelters,(41) transitional housing programs,(50) community/drop-in/crisis centres, (36, 40) residential drug treatment facilities, (43) (44) (45) (46) (47) 53) churches, (55) and meal programs or food banks. (34, 36) Some strategies were delivered in healthcare settings, including primary clinics (standard or for under-served groups), (34, (43) (44) (45) 48, 52, 54) a clinic in a shelter, (39) and emergency departments. (35, 37, 38) One study reported vaccinations being delivered via pharmacies, hospitals, mass vaccination events, foot teams, and mobile vans. (38) .

Some of these locations required participants to travel to staff, and others required staff to travel to participants. There was a roughly equal mix of single-site and multi-site strategies. In a cross-sectional study which compared vaccination strategies delivered at 'non-traditional' sites (e.g. shelters) and at 'traditional sites' (e.g. primary health clinics), it was found that a greater percentage of people experiencing homelessness were vaccinated at nontraditional sites. (34) .

Vaccination schedules: Eight of the studies involving multi-dose hepatitis B vaccines offered an accelerated vaccination schedule, as standard or as an option, with the aim of increasing rates of completion of the vaccine series. (36, (43) (44) (45) (46) (47) (48) (49) 54) In an RCT which compared an accelerated schedule (2x doses over 2 months) versus a standard schedule (3x doses over 6 months), more people completed the accelerated schedule (73.0% vs. 54.0%).(44) A longitudi-nal study testing an accelerated schedule also reported a similar finding.(54).

Most strategies (N = 15) gave the vaccine, or the first dose, at the participant's first appointment, even if their vaccination history or serological status were unknown. The remaining strategies required participants to wait until a second appointment, at one week, (46, 47) seven to ten days,(53) two weeks, (43) (44) (45) or four weeks(49) after the first. In one strategy, participants waited until a third appointment, as there was an additional planned delay associated with obtaining the vaccine from a pharmacy.(39) In a study involving vaccination at a second appointment two weeks after the first, it was found that 29.0% of participants failed to represent for their second dose. (43) However, another study about Hepatitis B vaccination found, via serological testing, that 42.0% of participants were already immune at their first appointment, and so received a vaccine unnecessarily. (56) .

Duration: The studies reported on vaccination strategies which operated for various lengths of time. Most of the strategies appeared to be ongoing, although the study itself was timelimited. Some strategies ran for a single day at each site. (30, 40, 41) Other strategies ran for the duration of the influenza season, (34, 55) or for the duration of an outbreak of disease. (37, 38, 51) .

The strategies were operated in a variety of formats. For example: one involved three 3-hour clinics per week, (35) and another involved bi-monthly clinics.(52) Another strategy operated two to three days per week at rotating sites.(36) Another involved a mass immunisation day when there were ! 6 people ready to be vaccinated, to save on vaccine shipping costs. (39) .

Staffing: The studies which described staffing identified nurses (including students, nursing assistants, registered nurses, nurse immunisers, nurse practitioners, and research nurses) as key staff members. (34, 37, (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) 52, 53, 55) Many strategies also involved physicians. (30, 34, 37, 39, 42, 48, 54, 55) Other professionals including pharmacists, outreach workers, mental health workers, social workers, laboratory workers, administration staff, program coordinators/directors, and computer support analysts were also involved. A number of the studies used 'gatekeepers', or people with access to people who are homeless. (34, 36, 40) .

Staff training: Six of the vaccination strategies began by training the staff involved -for example: about the signs/symptoms of an infectious disease, the behaviours which may increase infection risk in people who are homeless, the importance of vaccination for people who are homeless, and responsibilities related to receiving, storing, administering, and documenting vaccines. Training was typically delivered via information sessions and handouts. (34, 36, 37, 52) One study describes having coloured, laminated vaccination protocol cards for staff to wear. (37) .

Promotion: There were a variety of initiatives to promote vaccination. Some strategies used promotional materials -for example: cards, flyers, and posters with program times and locations, in locations frequented by people who are homeless. (36, 40, 41, (43) (44) (45) 53) In one study, staff handed out 'flu vaccine vouchers' with a map to the clinic.(41) Some strategies which relied on gatekeepers directed promotional materials to them. (36, 40) Others utilised outreach workers, who visited people to talk about vaccination. (36, 41) Often, people were told about vaccination in a health appointment or intake assessment. (35, (37) (38) (39) 48, 52, 55) .

Education: All the strategies offered education to people who are homeless, about infectious diseases and/or vaccination. Often, education and promotion (above) took place simultaneously. Education was frequently brief and intended only to facilitate informed consent. Sometimes, education was more robust and aimed at improving vaccine uptake. (34, 36, 39, 42, 52) For example: one strategy had a physician deliver a 30-minute talk to residents of a shelter immediately prior to the commencement of a vaccination (56) . Reminders: Many (N = 11) of the strategies involving the multidose hepatitis B vaccination implemented strategies to remind people to present for their next dose. Often, this involved providing people with a reminder card, perhaps in a protective pouch, with details of their next appointment. (36, 37, 48, 49, 56) Other studies implemented systems to remind people about their next vaccination, either routinely or opportunistically, if they presented to a clinic in-between vaccination doses. (48, 54) One study describes using 'active recall', which included contacting people by telephone and locating them through other services and facilities. (36) .

Incentives: Ten strategies offered an incentive to people for presenting for vaccination, or for re-presenting for subsequent doses in a vaccine series. Incentives included cash payments, ranging from USD$5 to USD$35 per episode of care. (43) (44) (45) 53, 56) Other incentives included clothing, toiletries, food vouchers, snacks, vitamins, and movie passes. (36, 52, 56) .

Seven RCTs tested combinations of education, reminders, and incentives. For example: one hepatitis A/B vaccination strategy involved 1x 20-minute nurse-led group education session, plus active recall by an outreach worker, plus incentives of USD$5 per dose. (43) (44) (45) These RCTs found that people receiving education, reminders, and incentives were more likely to complete a vaccine series, when compared with standard care (i.e. limited education, and/or limited or no tracking, and/or limited or no incentives), however this was not significant.

Co-interventions: Twelve strategies involved interventions in addition to vaccination ('co-interventions'). This included laboratory-based serological testing (with or without counselling) for the disease being vaccinated against or other diseases, mental and physical health screening, and/or drug and alcohol screening, with subsequent referrals if required. (36, (42) (43) (44) (45) (48) (49) (50) 53, 54) A number of the strategies also provided vaccinations to volunteers and staff. (38, 41, 51) .

Vaccine funding: Vaccines were funded in a variety of ways. In many of the US studies, vaccines were funded by a participants' health insurance, sometimes with an out-of-pocket co-payment (ranging from <$10 to $100).(34,39) If a person was un(der)insured, a clinic, health department, and/or vaccine manufacturer might fund the vaccine. (34, 39, 55) In other studies, vaccines were fully-funded by governments and/or vaccine manufacturers. (30, 37, 40, 48, 50, 52, 53) Lack of health insurance was a key reason for people declining vaccines. (39, 41) .

Strategy funding: Of the strategies which reported funding, all were government-funded. (34, 37, 48, 52) Two of the RCTs costed the strategies they reported on.(47,53) These identified the major cost to be associated with staffing, with additional costs associated with purchasing vaccines, serological testing, incentives, educational resources, and facility hire. (47, 53) Both RCTs identified greater costs associated with strategies which combined education, reminders, and incentives; costs ranged from USD$159 to $167 per patient.(47).

Details about the intervention outcomes outlined in this section are shown in Table 3 : Table 3A ..

Intervention efficacy: All the vaccination strategies were reported as being 'effective'. Most reported 'effectiveness' in terms of delivering vaccinations to people who are homeless -including as numbers of people receiving a vaccination, numbers of people completing each step in a vaccine series, and/or percentage of eligible people vaccinated in a given timeframe. (30, (36) (37) (38) (39) (40) (42) (43) (44) (45) (46) (47) (48) (50) (51) (52) (53) (54) Some reported 'effectiveness' in terms of improving vaccination rates from a known baseline or a previous timepoint. (34, 35, 41, 55, 56) .

Determinants of vaccine uptake: Nine studies identified determinants of vaccine uptake and/or vaccine series completion among participants. People accepting a vaccine or completing a vaccine series were more likely to have multiple comorbidities, to rate their health as 'fair' or 'poor', to be chronically homeless, to have a partner, to be part of a larger social group, and to be of an older age. (36, 39, 42, 43, 45, 46) People not accepting a vaccine or not completing a vaccine series were more likely to be newly homeless, to have used intravenous drugs, to have participated in a nonresidential substance abuse program, to have previously declined a vaccine, to have spent time in the out-of-home care and/or juvenile justice systems, and to have been hospitalised for mental illness. (43, 45, 46) One study found no determinants. (34) .

Enablers and barriers: The studies reported a variety of enablers and barriers associated with the vaccine strategies. The studies identified key enablers to be the use of multiple, convenient locations and times for vaccine delivery, and the incorporation of vaccination into routine health and social care. (34, 36, 48, 53, 55) These are particularly vital strategies considering one study found that two-fifths of people did not know where to go to receive a vaccine, and more than half of people lacked transportation to enable them to reach a vaccination site. (41) .

The studies identified a key barrier as a delay in the receipt of vaccines from manufacturers and dispensing pharmacies, either because of the need for a pharmacist to review a vaccine order or because of lack of suitable on-site storage facilities (i.e. a vaccine freezer). (34, 35, 39) To overcome this, some strategies used a 'oneclick' electronic system to increase the efficiency of the ordering process. (35, 38) Another strategy stored vaccines in a refrigerator at the vaccination site, so vaccines were dispensed independently of a pharmacy. (37) .

Another key barrier identified in the studies was mistrust among people who are homeless -about healthcare generally, and about vaccinations specifically. If people who are homeless interact with healthcare providers on an irregular/limited basis, mistrust is often high. (34) The studies also identified that misinformation about vaccination is common, and that people subsequently misunderstand their infection risk and the importance of vaccination. (34, (39) (40) (41) 56) Delivery of vaccines sites which are readily accepted by people who are homeless, already used by them, and staffed by people known to them may help to overcome these barriers. (48) . Finally, the studies identified that strong partnerships between key stakeholders -including the health and social care staff working with people who are homeless -to be a key enabler. (36) (37) (38) (39) A number of the studies took this further, involving people who are homeless themselves in strategy design and delivery. (34, 36) The co-design process was not evaluated, however.

Most (N = 22) studies were of moderate to high quality, with a low risk of bias, and therefore suitable to inform evidence-based practice. The remaining study was evaluated to be of lower quality,(30) though it was published in the form of a short report with relatively limited detail. There were seven RCTs, but the remaining studies were simpler cross-sectional or single-arm longitudinal studies which are inevitably associated with a degree of bias when interpreting effectiveness. The results of the quality assessment are provided in Supplement 2.

This systematic review identified 19 strategies, reported in 23 journal articles, which improved vaccination rates in people who are homeless. Most strategies were vaccination clinics, either fixed or mobile. Most were delivered, at least in part, by nurses. However, the strategies were diverse in their other characteristics. This emphasises the need for strategies to be responsive to the context in which they operate, and to the particular homeless population (s) they serve.

Although the strategies analysed in this review were diverse, a number of generalisations can be drawn. Firstly, though there are multiple options for vaccine delivery locations, 'non-traditional' sites -where staff travel to people who are homeless, in areas convenient to them -are a key consideration. The need for sites which are convenient for people who are homeless is also emphasised in the broader literature. (57) (58) (59) For COVID-19 vaccination, the CDC recommends vaccination at sites like shelters, meal services, and encampments. (60) .

The studies in this review emphasised using accelerated vaccination schedules for multi-dose vaccines, if available. They suggested vaccinating a person at their first appointment, regardless of if their vaccination history or serological status are known, if clinically safe. Although the strategies in this review ran for varying durations, the CDC recommends that COVID-19 vaccination strategies use longer durations to allow sufficient time for decision-making. (60) .

As noted, most of the vaccination strategies analysed in this review were delivered, at least in part, by nurses. Most began by training staff to work effectively with people who are homeless, if they have not done so before. Nurses who have had limited, or predominately negative, contact with people who are homeless frequently hold stereotyped views of this group.(61) Education may improve nurses' attitudes towards people who are homeless, and this may improve the willingness of people who are homeless to present (including for vaccination). (62) .

Most of the vaccination strategies analysed in this review used one or more methods of promotion. Research consistently shows that between 30% and 40% of people who are homeless do not intend to be vaccinated for COVID-19. (63) (64) (65) Considering the significant misinformation circulating about COVID-19 and COVID-19 vaccines,(66) promotion may be particularly vital for COVID-19 vaccination strategies. The CDC emphasises the need for clear, consistent messaging with people who are homeless about COVID-19 vaccination. (60) .

The review returned unclear findings about the effectiveness of education, reminders, and incentives in vaccination strategies for people who are homeless. Studies in the broader population agree that education, reminders, and incentives have variable impacts on vaccination uptake and series completion. (67) (68) (69) The use of these incentives may depend on a strategy's budget. However, the studies show active recall is important, and the CDC agrees active recall is a vital component of vaccination strategies for people who are homeless. (60) .

Many of the strategies analysed in this review included cointerventions. These are important opportunities to 'capture' people who are homeless, who are often infrequent healthcare users, as they present to health services. However, many vaccination strategies for people who are homeless have limited funding, staff, and resources and this may impede their ability to effectively deliver co-interventions.(58) A co-intervention which should be considered is the vaccination of volunteers and staff.(60) This may be a vital aspect of COVID-19 vaccination strategies, as rates of COVID-19 infection among volunteers and staff are often high. (13) .

In most of the strategies analysed in this review, vaccines were free for people who are homeless -and where this was not the case, cost was a barrier to uptake. That funded vaccines are an enabler to uptake in people who are homeless is also a finding in the broader literature. (58, 70) In a study about the vaccination capability of homeless health services in the US, it was found that most services are confident navigating reimbursement systems. (71).

The studies included in this review identified multiple barriers to vaccination in people who are homeless. They also identified a key enabler: stakeholder collaboration. The broader literature also identifies collaboration as vital to the success of vaccination strategies, (58, 71) and it is a key recommendation for COVID-19 vaccination strategies.(60) Collaboration should go beyond service providers, however: research shows that people who are homeless themselves value the opportunity to become involved in activities related to vaccination.(72).

The review has some limitations. Some studies reported on vaccination strategies secondary to disease outbreaks and/or broader public health activities, and it is possible that similar studies were overlooked if they were not read in full-text. Studies may have also been overlooked if they were not available on one or more of the databases searched. The review only included studies undertaken in higher-income countries, and the results may not be generalised to other contexts. Further, there were no studies about vaccination strategies specific to COVID-19. There was a lack of RCTs, and we were unable to analyse studies using quantitative methods. No studies were identified that considered approaches to catch-up vaccination for multi-dose vaccines.

This systematic review has identified, analysed the characteristics of, and evaluated the outcomes of, strategies to improve vaccination rates in people who are homeless. The strategies identified were diverse in their characteristics and their outcomes; however, generalisations about 'what works' could be made. These are vital to informing evidence-based vaccination practice, and to improving related health outcomes, in people who are homeless.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Organisation for Economic Cooperation and Development. HC3.1 Homeless population 2020

Homelessness and hepatitis A -San Diego County

Hepatitis A outbreak in San Diego County, 2016-2017: A morphologic and epidemiologic review

Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus among homeless and nonhomeless United States veterans

Factors influencing the uptake of influenza vaccine vary among different groups in the hard-to-reach population

Risk for invasive Streptococcal infections among adults experiencing homelessness

Homelessess in adults with invasive pneumoccal disease in Calgary

Outbreak of invasive Streptococcus pneumoniae among an inner-city population in Victoria

Tuberculosis among the homeless

Active tuberculosis among homeless persons

Active pulmonary tuberculosis and latent tuberculosis infection among homeless people in Seoul

The incidence of pulmonary tuberculosis among the homeless in north-eastern Poland

Assessment of SARS-CoV-2 infection prevalence in homeless shelters -Four US cities

Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston

COVID-19 outbreak among three affiliated homeless service sites

Pandemic planning in homeless shelters: A pilot study of a COVID-19 testing and support program to mitigate the risk of COVID-19 outbreaks in congregate settings

Assessment of SARS-CoV-2 infection through rapid serology testing in the homeless population in the City of Rome, Italy: Preliminary results

First wave of COVID-19 did not reach the homeless population in Aarhus

COVID-19 prevalence among people experiencing homelessness and homelessness service staff during early community transmission in

Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: A retrospective cohort study

Ethical vaccine distribution planning for pandemic influenza: Prioritizing homeless and hard-to-reach populations

Challenges to immunization: The experiences of homeless youth

Homeless persons' experiences of health and social care: A systematic integrative review. Health and Social Care in the Community

Mistrust of outreach workers and lack of confidence in available services among individuals who are chronically street homeless

Vaccination programs among urban homeless populations: A literature review

RoB 2: A revised tool for assessing risk of bias in randomised trials

Risk of bias in non-randomised studies of interventions (ROBINS-I) ND

Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) Available from

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

pandemic flu vaccination campaign: The homeless lesson

Postexposure effectiveness of varicella vaccine

Screening for tuberculosis: The port of arrival scheme compared with screening in general practice and the homeless

Facilitating risk reduction among homeless and street-involved youth

Increasing influenza vaccination acceptance in the homeless: A quality improvement project

Effect of a computerized alert on emergency department hepatitis A vaccination in homeless patients during a large regional outbreak

A hepatitis B vaccination outreach project for street youth in Montreal

Response to hepatitis A epidemic: Emergency department collaboration with public health commission

Public health role of academic medical center in community outbreak of Hepatitis A

Assessing and improving zoster vaccine uptake in a homeless population

An academic-community partnership to address the flu vaccination rates of the homeless

Viral hepatitis in a Canadian streetinvolved population

Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults

Feasibility of completing an accelerated vaccine series for homeless adults

Hepatitis A/B vaccine completion among homeless adults with history of incarceration

Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trial

A randomized clinical trial of tailored interventions for health promotion and recidivism reduction among homeless parolees: outcomes and cost analysis

Vaccination against hepatitis A and B in persons subject to homelessness in inner Sydney: vaccine acceptance, completion rates and immunogenicity

Positive impact of a shelter-based hepatitis B vaccine program in homeless Baltimore children and adolescents

Vaccine xxx (xxxx) xxx

Health services for homeless adolescents

An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands

Advancing the health of homeless populations through vaccinations

Cost-effective way to reduce stimulant-abuse among gay/bisexual men and transgender women: a randomized clinical trial with a cost comparison

Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users

Influenza vaccine community outreach: Leveraging an interprofessional healthcare student workforce to immunise marginalised populations

Strategies for improving influenza immunization rates among hard-to-reach populations

Vaccinating adolescents in high-risk settings: lessons learned from experiences with hepatitis B vaccine

Centres for Disease Control and Prevention. COVID-19 vaccination for people experiencing homelessness: Frequently asked questions 2021

Medical-surgical nurses' attitudes towards patients who are homeless: How attitudes develop and transform

Nurses' attitudes towards people who are homeless: A literature review

COVID-19 vaccine hesitancy among persons living in homeless shelters in France

Implications of COVID-19 vaccine uptake among young adults experiencing homelessness: A brief report

Acceptance of COVID-19 vaccine among persons experiencing homelessness in the City of

Planning for a COVID-19 vaccination program

Lottery-based incentive in Ohio and COVID-19 vaccination rates

Looking to the empirical literature on the potential for financial incentives to enhance adherence with COVID-19 vaccination

Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation

Interventions to increase vaccination rates in homeless adults aged 50 years and older in a shelter-based clinic

Vaccination capability inventory of community, migrant, and homeless health centers: A survey report

Use of community-based participatory research in preparing low income and homeless minority populations for future HIV vaccines

Australian Government -Department of Health

Vaccine xxx (xxxx) xxx